Amarin Moves Higher On Speculation Of Special Protocol Assessment
July 31, 2014 at 12:01 PM EDT
Amarin (NASDAQ: AMRN) moved higher Thursday following upbeat biotech commentary from TheStreet.com's Adam Feuerstein. Feuerstein ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.